ROBYN ANDERSON: Open Payments
NPI 1912447251 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,423 in 89 payments from 11 companies in 2025. Trend: 2023 $2,102 · 2024 $2,435 · 2025 $2,423
Food & beverage: $2,346Education: $77
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 22 | $673 |
| Janssen Biotech, Inc. | 12 | $403 |
| UCB, Inc. | 8 | $274 |
| ABBVIE INC. | 14 | $269 |
| Novartis Pharmaceuticals Corporation | 11 | $248 |
| Mallinckrodt Hospital Products Inc. | 7 | $186 |
| AstraZeneca Pharmaceuticals LP | 4 | $145 |
| GlaxoSmithKline, LLC. | 6 | $105 |
| Radius Health, Inc. | 3 | $83 |
| Genentech USA, Inc. | 1 | $22 |
Products named: TREMFYA, Bimzelx, TAVNEOS, COSENTYX, ACTHAR, RINVOQ, SAPHNELO, EVENITY.
Industry payments across TX — which companies pay providers there.
